Comparative study of anthropometric measurements, liver function tests, hemoglobin and plasma glucose levels between individuals with alcohol abuse and controls
DOI:
https://doi.org/10.18203/2349-3933.ijam20193096Keywords:
Alcohol abuse, Body Mass Index, Liver function tests, Plasma glucoseAbstract
Background: Alcohol abuse is global burden to families as well as society. On the ‘years of life lost scale’, which is based on alcohol attributable years of life lost, India has been rated 4 on a scale of 1 to 5. This implies that the alcohol consuming population of our country loses most of the years of their life because of drinking and its consequences. The aim of this research is to compare anthropometric measurements, liver function tests, haemoglobin and plasma glucose levels in individuals with alcohol abuse and normal population.
Methods: The study was conducted in the Department of General Medicine, Civil Hospital, Aizawl. 84 cases of individuals with alcohol abuse (as per DSM-IV criteria) within the age group of 18-70 years and 70 age, sex, height and weight matched lifetime abstainers, healthy individuals were taken as controls from medicine department. They underwent a detailed clinical examination, anthropometric measurements, liver function tests, haemoglobin and plasma glucose levels.
Results: 15.5% of the individuals with alcohol abuse had hypertension. The mean post prandial glucose among the individuals with alcohol abuse was 116.8±12.3 mg/dl and among the controls was 121.1±11.0 mg/dl. Mean serum bilirubin 1.1 mg/dl, AST 79 IU/l & ALT was 79.6 in alcoholics. The mean serum bilirubin 0.8 mg/dl, AST 27.2 IU/l and ALT was 29.4 in non-alcoholics.
Conclusions: The individuals with alcohol abuse have raised serum bilirubin, AST and ALT levels compared to the non-alcoholics. Prevalence of hypertension is higher in the individuals with alcohol abuse compared to normal population.
References
O'shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver Diseases and the Practice Parameters Committee of the Am College of Gastroenterol. Alcoholic liver disease. Hepatol. 2010;51(1):307-28.
European Association for The Study of The Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J hepatol. 2012;57(2):399-420.
World Health Organization. Fact sheet: global status report on alcohol and health, 2014, 2014 ed. Available at: https://apps.who.int/iris/handle/10665/112736.
Diehl AM. Liver disease in alcohol abusers: clinical perspective. Alcohol. 2002;27(1):7-11.
Moussavian SN, Becker RC, Piepmeyer JL, Mezey E, Bozian RC. Serum gamma-glutamyl transpeptidase and chronic alcoholism. Digestive dis and sci. 1985;30(3):211-4.
Lian C: L’alcoollisme, cause d’hypertension artrielle. Bull Acad Med. 1915;74:525-528.
Chobanian AV, Bakris GL, Black HR et al. The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560.
Joosten MM, Beulens JW, Kersten S, Hendriks HF. Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetol. 2008;51(8):1375-81.
Funk M, Wutzke S, Kaner E, Anderson P, Pas L, McCormick R, et al World Health Organization Brief Intervention Study Group. A multicountry controlled trial of strategies to promote dissemination and implementation of brief alcohol intervention in primary health care: findings of a World Health Organization collaborative study. J studies on alcohol. 2005;66(3):379-88.
Lazarević AM, Nakatani S, Nešković AN, Marinković J, Yasumura Y, Stojičić D et al. Early changes in left ventricular function in chronic asymptomatic alcoholics: relation to the duration of heavy drinking. J Am College of Cardiol. 2000;35(6):1599-606.
Bell S, Daskalopoulou M, Rapsomaniki E, George J, Britton A, Bobak M et al Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records. BMJ. 2017;356:909.
Ceccanti M, Sasso GF, Nocente R, Balducci G, Prastaro A, Ticchi C.et al Hypertension in early alcohol withdrawal in chronic alcoholics. Alcohol and Alcoholism. 2005;41(1):5-10.
Girish N, Kavita R, Gururaj G, Benegal V. Alcohol use and implications for public health: patterns of use in four communities. Indian journal of community medicine: official publication of Indian Assoc Prevent & Social Med. 2010 Apr;35(2):238.
Kino M, Imamitchi H, Morigutchi M, Kawamura K, Takatsu T. Cardiovascular status in asymptomatic alcoholics, with reference to the level of ethanol consumption. Heart. 1981;46(5):545-51.
Kiechl S, Willeit J, Poewe W, Egger G, Oberhollenzer F, Muggeo M. et al Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). Bmj. 1996;313(7064):1040-4.
Paulson QX, Hong J, Holcomb VB, Nunez NP. Effects of body weight and alcohol consumption on insulin sensitivity. Nutri J. 2010;9(1):14.
Zilkens RR, Burke V, Watts G, Beilin LJ, Puddey IB. The effect of alcohol intake on insulin sensitivity in men: a randomized controlled trial. Diabetes care. 2003;26(3):608-12.
Stewart S, Prince M, Bassendine M, Hudson M, James O, Jones D et al. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. J hepatol. 2007;47(2):277-83.
Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. New Eng J Med. 2009;360(26):2758-69.
